Physician profile
Daniel G Cuadrado
NPI 1154398006
$514,266.16
in general payments reported to CMS, 2019-2025
12 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $14K · 2021: $30K · 2022: $84K · 2023: $110K · 2024: $118K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $232K · Consulting Fee: $53K · Travel and Lodging: $46K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $232,362.50 |
| Consulting Fee | $52,746.50 |
| Travel and Lodging | $46,491.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,750.00 |
| Food and Beverage | $13,684.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $324,913.45 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Zimmer Biomet Holdings, INC. | $176,658.19 | 2020-2025 | Ribfix Blu Advantage, Ribfix Titan, Advantagerib |
| Atricure, INC. | $7,452.95 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals Lp | $1,867.50 | 2024-2025 | Imfinzi |
| Pulmonx Corporation | $1,668.41 | 2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Davol INC. | $510.53 | 2022 | |
| Immersivetouch, INC. | $334.46 | 2025 | Immersivetouch |
| Medtronic, INC. | $309.00 | 2022-2025 | Surgidac, Endo Clip III, Surgipro Ll |
| Merit Medical Systems INC | $271.14 | 2023 | Aero Stent and Delivery System, Aeromini Stent and Delivery System |
| Galvanize Therapeutics, INC | $97.68 | 2024 | Aliya System |
| Bard Access Systems, INC. | $94.79 | 2019 | |
| Kci USA, INC. | $88.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cuadrado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.